Provided by Tiger Trade Technology Pte. Ltd.

Terns Pharmaceuticals, Inc.

52.95
0.0000
Volume:- -
Turnover:- -
Market Cap:6.11B
PE:-51.32
High:52.95
Open:52.95
Low:52.95
Close:52.95
52wk High:53.19
52wk Low:2.66
Shares:115.41M
Float Shares:113.00M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0319
EPS(LYR):-1.0326
ROE:-14.23%
ROA:-9.91%
PB:6.07
PE(LYR):-51.28

Loading ...

Tern backs Device Authority with new US$280,000 convertible loan investment

TIPRANKS
·
May 22

Tern plc raises £222,000 in new IoT-focused share placing

TIPRANKS
·
May 19

Tern’s Portfolio Firm Device Authority Seals IoT Security Deal with Xalient

TIPRANKS
·
May 12

Tern plc Secures Shareholder Backing for Open Offer and Capital Raise

TIPRANKS
·
May 08

Tern Raises £406,000 as Open Offer Draws 63% Take-up

TIPRANKS
·
May 08

Terns Pharmaceuticals Delists Following Merck Acquisition Completion

TIPRANKS
·
May 05

Merck completes acquisition of Terns Pharmaceuticals for $53 a share

Reuters
·
May 05

Mizuho Securities Downgrades Terns Pharmaceuticals to Neutral From Outperform, Trims Price Target to $53 From $54

MT Newswires Live
·
Apr 30

Terns Pharmaceuticals Cut to Perform From Outperform by Oppenheimer

Dow Jones
·
Apr 27

Terns Pharmaceuticals Gains FDA Breakthrough Status for TERN-701

TIPRANKS
·
Apr 27

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

GlobeNewswire
·
Apr 27

Oppenheimer Downgrades Terns Pharmaceuticals to Market Perform From Outperform

MT Newswires Live
·
Apr 27

Terns Pharmaceuticals Inc : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Apr 27

Terns Pharmaceuticals downgraded to Perform from Outperform at Oppenheimer

TIPRANKS
·
Apr 27

Rpt-Merck & Co Inc - Announces Hsr Waiting Period Expired for Terns Acquisition on April 23, 2026

THOMSON REUTERS
·
Apr 24

Corrected-Merck & Co Inc - on April 7 Commenced Cash Tender Offer for Terns at $53.00 per Share (Adds Dropped Words 'on Apirl 7')

THOMSON REUTERS
·
Apr 24

BRIEF-Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals

Reuters
·
Apr 24

Merck HSR waiting period expires for Terns acquisition offer at USD 53 a share

Reuters
·
Apr 24

Merck & Co Inc - Commences Cash Tender Offer for Terns at $53.00 per Share

THOMSON REUTERS
·
Apr 24

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

THOMSON REUTERS
·
Apr 24